Episensitization: Defying Timeâ€™s Arrow-Reference-Cited by-同舟云学术

Episensitization: Defying Timeâ€™s Arrow

Published:2015-06-11 Issue: Volume:5 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Oronsky Bryan T.,Oronsky Arnold L.,Lybeck Michelle,Oronsky Neil C.,Scicinski Jan J.,Carter Corey,Day Regina M.,Rodriguez Orengo Jose F.,Rodriguez-Torres Maribel,Fanger Gary F.,Reid Tony R.

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference74 articles.

1. Two case reports of resensitization to previous chemotherapy with the novel hypoxia-activated hypomethylating anticancer agent RRx-001 in metastatic colorectal cancer patients;Reid;Case Rep Oncol,2014

2. A mathematical model of the development of drug resistance to cancer chemotherapy;Birkhead;Eur J Cancer Clin Oncol,1987

3. Multiple Drug Resistance in Cancer 2

4. The (dual) origin of epigenetics;Haig;Cold Spring Harb Symp Quant Biol,2004

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation;Molecular Cancer Therapeutics;2024-05-07

2. RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist;Frontiers in Oncology;2023-05-29

3. Immunotherapy for hepatocellular carcinoma: Recent advances and future targets;Pharmacology & Therapeutics;2023-04

4. Combinatory EHMT and PARP inhibition induces an interferon response and a CD8 T cell-dependent tumor regression in PARP inhibitor-resistant models;2023-02-23

5. Cancer: slaying the nine-headed Hydra;Annals of Oncology;2023-01